NCT07217574 Program in Oncology for Tribal Health Systems.
| NCT ID | NCT07217574 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oklahoma |
| Condition | Patient Outcomes |
| Study Type | OBSERVATIONAL |
| Enrollment | 187 participants |
| Start Date | 2026-02-11 |
| Primary Completion | 2030-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 187 participants in total. It began in 2026-02-11 with a primary completion date of 2030-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial aims to develop and implement more navigation assistance programs tailored specifically for Native American cancer patients, addressing the current lack of available support. The goal is to improve communication barriers within the healthcare system by fostering a collaborative approach between the Stephenson Cancer Center (SCC) and tribally operated healthcare systems (ITU). Through this partnership, the trial seeks to enhance patient outcomes by providing culturally sensitive, coordinated care.
Eligibility Criteria
Inclusion Criteria: * Participants must be at least 18 years of age, within eight weeks of newly diagnosed cancer confirmed by pathology/imaging, navigated through the NANP at SCC and have verbal fluency in English. Exclusion Criteria: * Participants in the Phase 1 open pilot will not be eligible for the Phase 2 RCT.
Contact & Investigator
Amanda Janitz, Ph.D.
PRINCIPAL INVESTIGATOR
University of Oklahoma Stephenson Cancer Center
Frequently Asked Questions
Who can join the NCT07217574 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Patient Outcomes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07217574 currently recruiting?
Yes, NCT07217574 is actively recruiting participants. Contact the research team at Amanda-Janitz@ou.edu for enrollment information.
Where is the NCT07217574 trial being conducted?
This trial is being conducted at Oklahoma City, United States.
Who is sponsoring the NCT07217574 clinical trial?
NCT07217574 is sponsored by University of Oklahoma. The principal investigator is Amanda Janitz, Ph.D. at University of Oklahoma Stephenson Cancer Center. The trial plans to enroll 187 participants.